Kymriah’s Impact on Health Insurance Finances Limited for Now: Health Minister

May 20, 2019
Health Minister Takumi Nemoto Health Minister Takumi Nemoto reiterated on May 17 that the impact of Novartis Pharma’s CAR-T cell therapy Kymriah (tisagenlecleucel), which received an NHI price of approximately 33.5 million yen, on health finances is limited. As the...read more